Chuck Royce's OGN Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 59,878 shares of Organon & Co. (OGN) worth $429,325, representing 0.00% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in OGN, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 169,630 shares. Largest reduction occurred in Q3 2025, reducing 696,419 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Organon & Co (OGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Organon & Co (OGN) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2021 | +546,803 | New Buy | 546,803 | $30.26 |
| Q3 2021 | -26,348 | Reduce 4.82% | 520,455 | $32.79 |
| Q4 2021 | -7,400 | Reduce 1.42% | 513,055 | $30.45 |
| Q1 2022 | -110,946 | Reduce 21.62% | 402,109 | $34.93 |
| Q2 2022 | -18,300 | Reduce 4.55% | 383,809 | $33.75 |
| Q3 2022 | -19,800 | Reduce 5.16% | 364,009 | $23.40 |
| Q4 2022 | -11,254 | Reduce 3.09% | 352,755 | $27.93 |
| Q1 2023 | -63,400 | Reduce 17.97% | 289,355 | $23.52 |
| Q2 2023 | +75,083 | Add 25.95% | 364,438 | $20.81 |
| Q3 2023 | +169,630 | Add 46.55% | 534,068 | $17.36 |
| Q4 2023 | +94,600 | Add 17.71% | 628,668 | $14.42 |
| Q1 2024 | +14,398 | Add 2.29% | 643,066 | $18.80 |
| Q2 2024 | +29,278 | Add 4.55% | 672,344 | $20.70 |
| Q3 2024 | +30,750 | Add 4.57% | 703,094 | $19.13 |
| Q4 2024 | +166,300 | Add 23.65% | 869,394 | $14.92 |
| Q1 2025 | -22,624 | Reduce 2.60% | 846,770 | $14.89 |
| Q2 2025 | -93,846 | Reduce 11.08% | 752,924 | $9.68 |
| Q3 2025 | -696,419 | Reduce 92.50% | 56,505 | $10.68 |
| Q4 2025 | +3,373 | Add 5.97% | 59,878 | $7.17 |
Chuck Royce's Organon & Co Investment FAQs
Chuck Royce first purchased Organon & Co. (OGN) in Q2 2021, acquiring 546,803 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Organon & Co. (OGN) for 19 quarters since Q2 2021.
Chuck Royce's largest addition to Organon & Co. (OGN) was in Q2 2021, adding 546,803 shares worth $16.55 M.
According to the latest 13F filing for Q4 2025, Chuck Royce's firm, Royce & Associates Lp, owns 59,878 shares of Organon & Co. (OGN), valued at approximately $429,325.
As of the Q4 2025 filing, Organon & Co. (OGN) represents approximately 0.00% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Organon & Co. (OGN) was 869,394 shares, as reported at the end of Q4 2024.